✦ LIBER ✦

No reactive hypoglycemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and I.V. glucose

✍ Scribed by Tina Vilsbøll; Thure Krarup; Sten Madsbad; JensJ. Holst

Book ID: 117369698
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 215 KB
Volume: 50
Category: Article
ISSN: 0168-8227
DOI: 10.1016/s0168-8227(00)81599-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circadian rhythms of GIP and GLP1 in glu

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

✍ G. Mingrone; G. Nolfe; G. Castagneto Gissey; A. Iaconelli; L. Leccesi; C. Guidon 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 225 KB

Pancreatic β-cell responses to GLP-1 aft

Pancreatic β-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes

✍ Meena Asmar; Patricia V. Højberg; Carolyn F. Deacon; Kristine Hare; Jens J. Hols 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 378 KB

Long-term administration of theophylline

Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with Type 1 diabetes mellitus

✍ Hvidberg, A.; Rosenfalck, A.; Christensen, N.J.; Hilsted, J. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

The methylxanthine theophylline increases intrahepatic c-AMP and c-AMP mediates the hepatic glucose response to adrenaline and glucagon. Intravenous theophylline increases glucose recovery during acute insulin-induced hypoglycaemia and caffeine increases hypoglycaemia awareness and glucoregulatory h

Secretion of incretin hormones (GIP and

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

✍ Michael A. Nauck; Andrea El-Ouaghlidi; Bartholomäus Gabrys; Katrin Hücking; Jens 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Pharmacokinetic and pharmacodynamic prop

Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes

✍ C. Kapitza; T. Heise; P. Birman; K. Jallet; J. Ramis; R. Balena 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Gastric emptying, glucose responses, and

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)- (7-36) amide in type 2 (noninsulin-dependent) diabetic patients

✍ Willms, B. 📂 Article 📅 1996 🏛 Endocrine Society 🌐 English ⚖ 735 KB